Walleye Capital’s Revelation Biosciences Warrant REVBW Stock Holding History

Walleye Capital’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,074	Closed	-$71	–	4994
2024 Q4	$71	Sell	10,074 -176,927	-95%	-$2.07K	﹤0.01%	4748
2024 Q3	$2.81K	Hold	187,001	–	–	﹤0.01%	5056
2024 Q2	$3.74K	Hold	187,001	–	–	﹤0.01%	5356
2024 Q1	$4.96K	Hold	187,001	–	–	﹤0.01%	5154
2023 Q4	$1.98K	Hold	187,001	–	–	﹤0.01%	4764
2023 Q3	$3.16K	Hold	187,001	–	–	﹤0.01%	4659
2023 Q2	$3.33K	Hold	187,001	–	–	﹤0.01%	4091
2023 Q1	$3.03K	Buy	+187,001	New	+$4.69K	﹤0.01%	3723
2022 Q3	–	Sell	-107,417	Closed	-$9K	–	3486
2022 Q2	$9K	Hold	107,417	–	–	﹤0.01%	2030
2022 Q1	$14K	Buy	107,417 +90,478	+534%	+$23.1K	﹤0.01%	2034
2021 Q4	$12K	Sell	16,939 -90,837	-84%	-$55.7K	﹤0.01%	2008
2021 Q3	$67	Hold	107,776	–	–	﹤0.01%	1368
2021 Q2	$69	Buy	107,776 +36,776	+52%	+$21.9K	﹤0.01%	1206
2021 Q1	$37	Buy	+71,000	New	+$66.4K	﹤0.01%	1082

Other funds holding REVBW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PIS

POM Investment Strategies Raleigh, North Carolina $80.5M AUM 16.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Walleye Capital's REVBW Position: Q1 2025 in Review

Walleye Capital sold out of Revelation Biosciences Warrant (REVBW) in Q1 2025, closing a stake of 10,074 shares — an estimated $71 sold.

Walleye Capital first reported a position in REVBW in Q1 2021 and held it in 14 quarters. The position peaked at $14K in Q1 2022. 9 funds tracked by Wall St. Rank hold REVBW as of Q1 2025.

Walleye Capital reported no remaining Revelation Biosciences Warrant position as of Q1 2025 after selling out during the quarter.
Walleye Capital sold 10,074 Revelation Biosciences Warrant shares in Q1 2025, an estimated $71.
Walleye Capital first reported a position in Revelation Biosciences Warrant in Q1 2021 and held it in 14 quarters.
Walleye Capital's Revelation Biosciences Warrant position peaked at $14K in Q1 2022.
9 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.